Showing results (101-110 of 108) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 108 results.
The Annals of Thoracic Surgery|September 3, 2015
Outcomes of Patients With Severe Chronic Lung Disease Who Are Undergoing Transcatheter Aortic Valve ReplacementRakesh M Suri, Brian C Gulack, J Matthew Brennan, et al.
Circulation. Cardiovascular Interventions|April 19, 2019
Clopidogrel PharmacogeneticsNaveen L Pereira, Charanjit S Rihal, Derek Y F So, et al.
The Journal of Clinical Endocrinology and Metabolism|January 13, 2023
Diazoxide Choline Extended-Release Tablet in People With Prader-Willi Syndrome: A Double-Blind, Placebo-Controlled TrialJennifer L Miller, Evelien Gevers, Nicola Bridges, et al.
Pharmacogenetics and Genomics|February 7, 2019
International survey of patients undergoing percutaneous coronary intervention and their attitudes toward pharmacogenetic testingNaveen L Pereira, Derek So, Jang-Ho Bae, et al.
European Journal of Human Genetics : EJHG|January 28, 2010
Methylation analysis of 79 patients with growth restriction reveals novel patterns of methylation change at imprinted lociClaire Louise Susan Turner, Deborah M Mackay, Jonathan L A Callaway, et al.
JACC. Cardiovascular Interventions|September 2, 2019
Outcomes of Veterans Undergoing TAVR Within Veterans Affairs Medical Centers: Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking ProgramPhilip S Hall, Colin I O'Donnell, Verghese Mathew, et al.
JACC. Cardiovascular Interventions|April 12, 2023
Genetic-Guided Oral P2Y<sub>12</sub> Inhibitor Selection and Cumulative Ischemic Events After Percutaneous Coronary InterventionBrenden S Ingraham, Michael E Farkouh, Ryan J Lennon, et al.
JAMA|August 26, 2020
Effect of Genotype-Guided Oral P2Y12 Inhibitor Selection vs Conventional Clopidogrel Therapy on Ischemic Outcomes After Percutaneous Coronary Intervention: The TAILOR-PCI Randomized Clinical TrialNaveen L Pereira, Michael E Farkouh, Derek So, et al.
Pageof 11